SynthesisMedicine2018

The efficiency of endothelin receptor antagonist bosentan for pulmonary arterial hypertension associated with congenital heart disease: A systematic review and meta-analysis.

Hong-Yu Kuang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.